Fundraising FoxPolyCore Therapeutics
Philadelphia, US · Founded 2022 · Delaware corporation · 2 known investors
Find your way into PolyCore Therapeutics
Sign up to see every warm intro you have to PolyCore Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PolyCore Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KB
Kelly BeckMs. Beck is the Chief Executive Officer of the Issuer.
CC
Christopher CashmanNamed on SEC filing
FC
Frederick CalloriNamed on SEC filing
JB
James B. HarrisNamed on SEC filing
Board
CG
Chris GarabedianBoard director
Investors · 2
Also in the syndicate · 2
Ben Franklin Technology Partners of Southeastern PennsylvaniaXontogeny, LLC
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 1 round · 2022
▶$4.7MraisedMar 2022 · 5 investors · BiotechnologyRule 506(b)
▶$4.7MraisedMar 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher CashmanDirector
- Kelly BeckExecutive Officer, Promoter, Director
- Frederick CalloriDirector
- Chris GarabedianDirector
- James B. HarrisDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has PolyCore Therapeutics raised?
- PolyCore Therapeutics has disclosed $4.7M raised across 1 round.
- Where is PolyCore Therapeutics headquartered?
- PolyCore Therapeutics is headquartered in Philadelphia, US.